Clinical trials data
Verbal Learning in aging, frailty and exercise trials: 128 registered studies
Every registered aging, frailty and exercise study on ClinicalTrials.gov that names Verbal Learning in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered aging, frailty and exercise studies name it in an outcome measure
- 128
- Name it in a primary outcome, 39%
- 50 of 128
Tests named in the same studies
- 1
Trail Making Test56 studies, 17 as a primary outcome
- 2
Stroop Color-Word Test38 studies, 13 as a primary outcome
- 3
Verbal Fluency34 studies, 6 as a primary outcome
- 4
Symbol Coding33 studies, 9 as a primary outcome
- 5
Digit Span Test30 studies, 16 as a primary outcome
- 6
Short Story Recall12 studies, 5 as a primary outcome
- 7
Picture Order Memory Test11 studies, 5 as a primary outcome
- 8
Picture Naming Test11 studies, 3 as a primary outcome
- 9
Category Fluency9 studies, 5 as a primary outcome
- 10
Dimensional Change Card Sort9 studies, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 2 | 2 |
| 2014 | 4 | 2 |
| 2015 | 7 | 2 |
| 2016 | 3 | 1 |
| 2017 | 10 | 2 |
| 2018 | 7 | 3 |
| 2019 | 9 | 6 |
| 2020 | 10 | 5 |
| 2021 | 9 | 4 |
| 2022 | 15 | 6 |
| 2023 | 17 | 3 |
| 2024 | 8 | 4 |
| 2025 | 12 | 3 |
| 2026 | 8 | 2 |
Phases and study sizes
By phase
- Early phase 11 studies, 0 as a primary outcome
- Phase 13 studies, 1 as a primary outcome
- Phase 26 studies, 3 as a primary outcome
- Phase 2/31 studies, 1 as a primary outcome
- Phase 32 studies, 1 as a primary outcome
- Phase 42 studies, 0 as a primary outcome
- Not applicable94 studies, 40 as a primary outcome
- Observational19 studies, 4 as a primary outcome
Participants per study
- Not applicable78 median, 40 to 120
- Observational172 median, 50 to 291
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 93 | 78 | 40 to 120 |
| Observational | 18 | 172 | 50 to 291 |
When aging, frailty and exercise trials measure it
Latest time point of each outcome
- Within a day15 outcomes, 4 as a primary outcome
- Up to 4 weeks15 outcomes, 5 as a primary outcome
- 1 to 3 months39 outcomes, 17 as a primary outcome
- 3 to 6 months22 outcomes, 9 as a primary outcome
- 6 to 12 months16 outcomes, 5 as a primary outcome
- 1 to 2 years7 outcomes, 2 as a primary outcome
- Over 2 years7 outcomes, 6 as a primary outcome
- No duration given7 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
121 of the 128 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting26 studies, 8 as a primary outcome
- Not yet recruiting6 studies, 2 as a primary outcome
- Active, not recruiting4 studies, 2 as a primary outcome
- Completed65 studies, 28 as a primary outcome
- Stopped early8 studies, 3 as a primary outcome
- Status unknown19 studies, 7 as a primary outcome
What they test
- Behavioral51 studies, 15 as a primary outcome
- Drug13 studies, 5 as a primary outcome
- Device16 studies, 10 as a primary outcome
- Dietary supplement16 studies, 7 as a primary outcome
- Diagnostic test2 studies, 1 as a primary outcome
- Combination product3 studies, 1 as a primary outcome
- Other35 studies, 16 as a primary outcome
- None given8 studies, 1 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States54 studies, 27 as a primary outcome
- Canada8 studies, 2 as a primary outcome
- United Kingdom8 studies, 1 as a primary outcome
- Sweden6 studies, 0 as a primary outcome
- China5 studies, 0 as a primary outcome
- Hong Kong5 studies, 2 as a primary outcome
- Spain5 studies, 3 as a primary outcome
- Switzerland5 studies, 0 as a primary outcome
- Italy4 studies, 1 as a primary outcome
- Portugal4 studies, 3 as a primary outcome
- Denmark3 studies, 0 as a primary outcome
- Netherlands3 studies, 0 as a primary outcome
24 countries in all. A study with sites in several counts in each; 4 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed aging, frailty and exercise studies that name Verbal Learning: 34 of 65, 52%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed aging, frailty and exercise studies that name Verbal Learning | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 8, 12% | 776, 10% |
| Results on ClinicalTrials.gov only | 10, 15% | 1,139, 14% |
| A results paper only | 16, 25% | 1,711, 22% |
| Neither | 31, 48% | 4,327, 54% |
The 128 studies
128 studies match. 50 name Verbal Learning in a primary outcome. Median size 80 participants. Median time to the primary outcome: 13 weeks.
Loading 128 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 that started before 2000.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 2 | 2 |
| 2014 | 4 | 2 |
| 2015 | 7 | 2 |
| 2016 | 3 | 1 |
| 2017 | 10 | 2 |
| 2018 | 7 | 3 |
| 2019 | 9 | 6 |
| 2020 | 10 | 5 |
| 2021 | 9 | 4 |
| 2022 | 15 | 6 |
| 2023 | 17 | 3 |
| 2024 | 8 | 4 |
| 2025 | 12 | 3 |
| 2026 | 8 | 2 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 3, other 125. Interventional 109, observational 19.
As a primary outcomeSecondary or other outcomeVerbal Learning
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07702994 | Start2026 | PhaseNot applicable | ConditionsAging, frailty and exercise, Lung disease | Participants210 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07628686 | Start2026 | PhaseNot applicable | ConditionsAging, frailty and exercise | Participants120 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07624630 | Start2026 | PhaseObservational | ConditionsStroke, Aging, frailty and exercise | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07533084 | Start2026 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Aging, frailty and exercise | Participants265 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07504120 | Start2025 | PhaseNot applicable | ConditionsMultiple sclerosis, Depression and bipolar disorder, Aging, frailty and exercise, Pain and fatigue | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07485062 | Start2026 | PhasePhase 4 | ConditionsAging, frailty and exercise, Obesity and diabetes | Participants164 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07314762 | Start2023 | PhaseObservational | ConditionsAging, frailty and exercise, Delirium, surgery and intensive care | Participants1,200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07298876 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise, Sleep and sleep disorders | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07208279 | Start2025 | PhaseNot applicable | ConditionsHealthy volunteers, Aging, frailty and exercise | Participants16 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07203196 | Start2025 | PhaseNot applicable | ConditionsAging, frailty and exercise, Obesity and diabetes, Sleep and sleep disorders | Participants16 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07171450 | Start2026 | PhaseNot applicable | ConditionsAging, frailty and exercise | Participants75 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07170943 | Start2021 | PhaseNot applicable | ConditionsAging, frailty and exercise | ParticipantsNot given | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT07165977 | Start2024 | PhaseNot applicable | ConditionsAging, frailty and exercise | Participants110 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07108413 | Start2024 | PhaseNot applicable | ConditionsAging, frailty and exercise | Participants72 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06948149 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise | Participants140 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06948136 | Start2025 | PhasePhase 1 | ConditionsAging, frailty and exercise | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06906276 | Start2025 | PhaseObservational | ConditionsParkinson's disease, Aging, frailty and exercise | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06901869 | Start2025 | PhaseObservational | ConditionsParkinson's disease, Aging, frailty and exercise | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06896825 | Start2025 | PhaseNot applicable | ConditionsHealthy volunteers, Aging, frailty and exercise | Participants86 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06854731 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise | Participants328 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06828783 | Start2022 | PhaseNot applicable | ConditionsAging, frailty and exercise | Participants90 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06821828 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise | Participants114 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06773416 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise, Sleep and sleep disorders | Participants206 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06722976 | Start2024 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06715995 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants52 | Lead sponsorOther | StatusRecruiting | Library tests named
|
Questions, answered from the data
How many aging, frailty and exercise trials use Verbal Learning?
128 registered aging, frailty and exercise studies on ClinicalTrials.gov name it in an outcome measure, 50 of them in a primary outcome: 9% of the condition's 1,398 studies with a cognitive outcome, against 11% of all of them. It is the 5th most named test in aging, frailty and exercise trials.
Which tests do aging, frailty and exercise trials use with Verbal Learning?
The Trail Making Test (56 studies), the Stroop Color-Word Test (38 studies) and Verbal Fluency (34 studies).
When do aging, frailty and exercise trials measure Verbal Learning?
Half of the primary outcomes that name Verbal Learning are measured within 13 weeks of the start, and the middle half from 8 weeks to 7 months. 48 primary outcomes give a duration.
How many completed aging, frailty and exercise trials that use Verbal Learning have reported results?
34 of the 65 completed studies that name it, 52%, have reported results: 18 posted them on ClinicalTrials.gov, 24 have a results paper linked to the registry record, and 8 did both. The other 31 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Verbal Learning and Grocery Trip Game as one test family, so this page counts their studies together.
Run Verbal Learning in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.